OLMA (OLMA) Stock Price & Analysis
OLMA (OLMA) rose 0.19% to USD 10.75 as of September 8, 2026 at 04:59 UTC, according to Nexqual real-time market data.
OLMA last closed at USD 10.75; the session ranged USD 10.57–10.85 on volume of 505,266 shares. Market capitalization is —, with a 52-week range of USD 6.65–36.26 (NMS). Source: Nexqual, September 8, 2026 at 04:59 UTC.
Key Statistics (as of September 8, 2026 at 04:59 UTC)
| Price | USD 10.75 |
|---|---|
| Change | ▲ 0.19% (up) |
| Previous Close | USD 10.75 |
| Open | USD 10.75 |
| Day Range | USD 10.57 – 10.85 |
| 52-Week Range | USD 6.65 – 36.26 |
| Volume | 505,266 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (OLMA)
Nexqual's technical model rates OLMA "SELL" based on 1 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 04:59 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.5 (neutral) |
| vs SMA50 | Below (USD 11.4) |
| MACD | -0.19 (negative) |
From OLMA's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ORIC | Oric Pharmaceuticals, Inc. | USD 12.86 | ▼ 2.06% |
| CGEM | Cullinan Therapeutics, Inc. | USD 22.09 | ▼ 1.07% |
| PRAX | Praxis Precision Medicines, Inc | USD 351.81 | ▼ 1.59% |
| FDMT | 4D Molecular Therapeutics, Inc. | USD 14.97 | ▲ 0.2% |
| ALXO | ALX Oncology Holdings Inc. | USD 2.01 | ▼ 3.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:59 UTC. This page is informational and not investment advice.